
Sign up to save your podcasts
Or


Beijing will let companies submit to U.S. audit requirements. In this Viewsroom podcast, Breakingviews columnists argue only weak firms will comply. Also, Pfizer and Moderna’s legal battle is unlikely to create a winner, and Britain’s prime ministerial hopefuls debate handouts.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Reuters4.2
4646 ratings
Beijing will let companies submit to U.S. audit requirements. In this Viewsroom podcast, Breakingviews columnists argue only weak firms will comply. Also, Pfizer and Moderna’s legal battle is unlikely to create a winner, and Britain’s prime ministerial hopefuls debate handouts.
Learn more about your ad choices. Visit megaphone.fm/adchoices

7,845 Listeners

4,215 Listeners

529 Listeners

4,416 Listeners

296 Listeners

435 Listeners

34 Listeners

684 Listeners

656 Listeners

1,086 Listeners

64 Listeners

310 Listeners

148 Listeners

146 Listeners

26 Listeners